A recent tweak to a Medicaid formula could be behind the shakeup to inhaler products, a series of changes which have both ...

Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Inhalers ...

Merck (NYSE: MRK) stock has been a longtime winner for investors, returning 72% in the past five years. A major factor in ...

Three years ago, the cigarette giant acquired Vectura, a British pharmaceutical firm that makes asthma inhalers, raising ...

No other batches or other 3M inhaler products are affected. Dr Richard Spiers, 3M medical director, said: "3M Health Care regrets any inconvenience and concern that this matter may cause to patients.

When a pharmaceutical company such as Merck has an extremely successful product such as Keytruda, it can be both a blessing and a curse. Keytruda is a significant source of revenue growth for the ...

Boehringer Ingelheim is the latest company in respiratory health to announce a collaboration to create a 'smart' version of an inhaler product. Boehringer Ingelheim (BI) is to work with ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Merck & Co., Inc. is a health care company ... animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.